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Abstract
Background: To evaluate the reliability and construct validity of a Greek version of the NEI-VFQ-25 in patients
with chronic ophthalmic diseases.
Methods: We developed the Greek version of the instrument using forward and backward translation. One
hundred-eighty-six patients responded to the questionnaire. To examine reliability, Cronbach's alpha for each
subscale was used as an index of internal consistency. Test-retest reliability was evaluated with intraclass
correlation coefficients. Regarding construct validity, both convergent and discriminant validities were calculated
by means of multi-trait analysis. Rasch analysis was used to estimate the visual ability required by each item for a
particular response, and each patient's visual ability. Correspondingly, instrument validity was evaluated by
estimating the distribution of residuals for item and subject measures.
Results: Four patient groups were studied, each including participants with a single cause of visual impairment.
Group 1 consisted of 84 glaucoma subjects. Group 2 included 30 subjects with age-related macular degeneration
(ARMD); group 3 included 25 subjects with dry-eye syndrome, whereas group 4 included 18 cataract patients.
Twenty-nine healthy individuals comprised the control group. NEI-VFQ scores (mean ± SD) for the glaucoma,
ARMD, dry-eye, cataract and control groups were: 76.9 ± 20.2, 70.9 ± 20.2, 81.6 ± 16.5, 73.5 ± 24.0 and 93.7 ±
8.9 respectively. Item analysis revealed no significant data skewing. Cronbach's alpha ranged from 0.678 to 0.926,
with most subscales having high internal consistency. Intraclass correlation coefficient ranged from 0.717 to 0.910
for all subscales. All items passed the convergent and discriminant validity tests. Strong correlations were
detected between visual acuity and "general vision", "distant activities" and "near activities" subscales. Significant
correlations were also detected between visual field deficits and the "peripheral vision" and "general vision"
subscales. Rasch analysis revealed potential weaknesses of the instrument that are associated with the
assumptions of the model itself. Specifically, low precision of the "agreement" items was detected in the estimation
of visual ability. Twenty-three percent of the subjects had fit statistics that fell outside the tolerance box.
Conclusion: Although traditional validation methods indicated that the Greek version of the NEI-VFQ-25 is a
valid and reliable instrument for VS-QoL assessment, Rasch analysis detected significant misfits to the model,
especially of the "agreement" items. This means that results of the corresponding subscales should be interpreted
with extreme caution.
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Background
The impact of ophthalmic diseases on quality of life
(QoL) has been documented in a series of studies [1-4].
Numerous instruments have been developed: general,
vision-specific, or disease specific ones (i.e. glaucoma-spe-
cific QoL instruments) that evaluate patients' subjective
perceptions regarding QoL [5-8]. In the majority of QoL
studies, an association is attempted between objective
clinical indices that quantify functional status and a series
of quality dimensions that purportedly reflect QoL. How-
ever, vision-specific QoL (VS-QoL) studies in Greek pop-
ulations are fragmented. In fact, apart from the prevalent
general QoL questionnaires, none of the vision-specific or
ophthalmic-disease-specific instruments has been vali-
dated in Greek populations [9].
The NEI-VFQ 25 (National Eye Institute visual function
questionnaire) is a widely used vision-specific instrument
for the assessment of VS-QoL. The instrument was origi-
nally developed by the National Eye Institute mainly for
the English-speaking North American populations [10].
NEI-VFQ 25 is a short form of the original 51-item version
[11]. Reliability and validity of the English version of the
NEI-VFQ 25 have been evaluated and found comparable
to the 51-item version. NEI-VFQ 25 measures the follow-
ing vision-depended functions: General health, general
vision, ocular pain, near activities, distant activities, social
functioning, mental health, role difficulties, dependency,
driving, color vision and peripheral vision. A 0–100 point
scale is used for subscale scores. A score of 100 indicates
the best possible score, while 0 indicates the worse possi-
ble score. With slight modifications, the original NEI-VFQ
25 has been translated and validated for other popula-
tions as well [12-15]. The original NEI-VFQ 25 has been
used as an index of VS-QoL for a series of diseases that
exert variable impact on visual functional capacity,
including glaucoma [16], age-related macular degenera-
tion [17], diabetic eye disease [18], dry eye syndrome
[19], blepharospasm [20], and retinitis pigmentosa [21].
Moreover, the instrument has been used as an index of the
impact of therapeutic interventions and rehabilitation
programs on VS-QoL [22-24].
The aim of our study was the evaluation of the reliability
and validity of NEI-VFQ 25 in a sample of native Greek
subjects with a series of common ophthalmic diseases.
Methods
Instrument development
The study adhered to the tenets of the Declaration of Hel-
sinki and approval was granted by the Bioethics Commit-
tee of the University of Thessaly. All participants provided
written informed consent.
For this study we developed a Greek version of the NEI-
VFQ 25. The original NEI-VFQ 25 is a VS-QoL instrument
that has been used in numerous studies. The concepts
investigated by the items have been extensively analyzed
both during the development of the original version and
during the validation of the instrument in other lan-
guages. Forward translation was done by native Greek
ophthalmologists with solid command of the English lan-
guage. Two independent bilingual speakers performed the
backward translation. Proper adaptation of the question-
naire to the experience of Greek patients mandated slight
modification of three questions. Thus, item "13" [How
much difficulty do you have visiting people at their
homes, at parties, or in restaurants?] was translated as:
[How much difficulty do you have visiting people at their
homes or outdoors, to restaurants, cafes, or in church?].
Accordingly, item "A7" [Because of your eyesight, how
much difficulty do you have taking part in active sports or
other outdoor activities that you enjoy (like golf, bowling,
jogging, or walking)?] was translated as: [Because of your
eyesight, how much difficulty do you have taking part in
active sports or other outdoor activities that you enjoy
(going long walks or jogging)?]. On the other hand, item
"9" [Because of your eyesight, how much difficulty do you
have going down steps, stairs, or curbs in dim light or at
night?] was modified as follows: [Because of your eye-
sight, how much difficulty do you have going down stairs,
or curbs in dim light or at night?], since the Greek words
for "stairs" and "steps" are almost identical. The Greek ver-
sion of the instrument was pilot-tested in a sample of ten
ophthalmic patients who visited the outpatient service of
our clinic for their annual check-up. The results of the
pilot-testing indicated that the instrument was well
accepted, since it was short in duration (about 10 min-
utes) and all items were easy to understand.
It should be mentioned that the NEI-VFQ 25 has already
been translated into Greek (Laboratory of Experimental
Ophthalmology of Aristotle University, Thessaloniki,
Greece, 2000) [25]. However, to our knowledge, it has not
been validated in native populations. In addition to the
aforementioned modifications required by the proper
adaptation of the instrument in Greek language, a series of
minor differences in the expression of the items suggested
a thorough revision of the translation process. Neverthe-
less, our translation of the NEI-VFQ 25 was almost identi-
cal to the one produced by the Laboratory of Experimental
Ophthalmology of the Aristotle University.
Study Design
Evaluation of the reliability and validity of the Greek ver-
sion of the NEI-VFQ 25 questionnaire was conducted by
the University Eye clinic, Larissa, Greece, between August
and November 2006. The University Hospital of Larissa is
an 800-bed General Hospital, located at the center ofBMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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mainland Greece, offering tertiary healthcare to more
than one million beneficiaries. The University Eye Clinic
provides integrated ophthalmic services to patients from
four counties in mainland Greece and one on the islands.
Two hundred fifty patients were recruited for the study. Of
them, 186 successfully responded to the questionnaire,
including the test-retest module (response rate: 74.4%).
The patients were randomly selected from the local
national health system hospitals of the corresponding
counties.
Subject groups
Subject group 1 consisted of a random sample of 84
known glaucoma patients (38 males/46 females). All sub-
jects had been diagnosed with primary open angle glau-
coma (POAG), pseudoexfoliation glaucoma (PXG),
pigment glaucoma (PG) or normal tension glaucoma
(NTG) at least two years prior to the study, and demon-
strated adequate compliance. Glaucoma patients had
bilateral typical glaucomatous visual field defects on
Humphrey 24-2 tests, untreated intraocular pressure
higher than 22 mmHg (except for the NTG patients) and
either retinal nerve fibre layer defects compatible with
glaucoma on OCT, or optic nerve heads with a typical
glaucomatous appearance. Subject group 2 consisted of a
random sample of 30 age-related macular degeneration
(ARMD) patients (14 males/16 females). To be eligible for
the ARMD group, each subject should have variable bilat-
eral involvement presenting either with geographic atro-
phy involving the fovea, choroidal neovascular
membrane, or pigment epithelium defects. Subject group
3 consisted of a random sample of 25 patients (1 male/24
females) diagnosed with dry-eye syndrome. These had
been diagnosed according to the European classification
criteria [26] and presented Schirmer score <5 mm at 5
minutes with abnormal Ocular Surface Discomfort Index
scores. Subject group 4 consisted of a random sample of
18 cataract patients (5 males/13 females). Cataract sub-
jects were recruited from the waiting lists for cataract
extraction. Among the eligibility criteria for all subjects
was the necessity for a single reason of visual impairment
that classified them accordingly to the abovementioned
groups. Subsequently, patients presenting more than one
causes of visual impairment (e.g. POAG and ARMD) were
excluded. Subjects with serious mental and/or major sys-
temic diseases were also excluded. The control group con-
sisted of a random sample of 29 adults (6 males/23
females) who visited the outpatient office for their annual
ophthalmic checkup and had no apparent cause of visual
impairment.
Data collection
Subjects responded to the self-administered Greek version
of the NEI-VFQ 25 in the presence of an independent
researcher who had no direct involvement in the provi-
sion of care. All questionnaires were completed prior to
the clinical examination. Clinical and demographic data
regarding the participants was retrieved from their medi-
cal records. Proxy responses (i.e. from family members)
were excluded.
Descriptive analysis and item analysis
Data from the different subject groups were used for the
item analysis. Missing values were estimated for each
item. Large ceiling or floor effects were evaluated as well.
Reliability
Reliability analysis was done by Cronbach's alpha estima-
tion as an index of internal consistency for each subscale
[27]. A time window of three weeks between two consec-
utive surveys (20 ± 5 days) was used for the assessment of
test-retest reliability. Quantification of test-retest reliabil-
ity was done using intraclass correlation coefficients.
Construct validity
Construct validity was evaluated by means of multi-trait
analysis according to Campbell and Fiske [28]. It is known
that convergent and discriminant validities are subtypes
of construct validity. According to the multitrait-multi-
method matrix, convergent validity is the degree to which
concepts that should be related theoretically are interre-
lated in reality, while discriminant validity is the degree to
which concepts that should not be related theoretically,
are in fact not interrelated in reality. In brief, each item was
hypothesized to belong to only one multi-item subscale
and correlations between the score on that item and the
scores on all the subscales were computed. Then, for each
item, if the correlation between the score on that item and
the score on the subscale to which that item belongs is 0.4
or higher, that item is validated in terms of convergent
validity. On the other hand, each item was validated for
discriminant validity if the correlation between the score
of the item and the score on the subscale where it belongs
is greater than all the correlations among the score of the
item and the remaining subscales.
Rasch analysis
Besides the traditional methods, the psychometric proper-
ties of the Greek NEI-VFQ 25 were also evaluated by Rasch
analysis. The item response theory has been described in
earlier studies [29,30]. Rasch models have been used in
the validation of a series of vision-specific and disease-
specific QoL instruments [31,32] as well as the assessment
of therapeutic interventions on QoL [33]. In brief, item
response models attempt to estimate the values of latent
variables on an interval scale from item scores that form
an ordinal scale. "Visual ability" is the variable of interest
regarding the assessment of visual function by means of
the item response theory. Each patient is supposed to have
a unique visual ability that determines the difficulty inBMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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performing certain daily tasks. In fact, each activity
requires a certain visual capacity in order to be performed
with ease.
The tests of construct validity measure the fit of the person
measures to the model, and the correlations of person-
and item parameter values with other variables, compared
with expected correlations. The tests of content validity
measure the fit of individual items to the model, the esti-
mation errors of item parameter values, and the spacing
and range of item parameter values, relative to the distri-
bution of person parameter values.
Statistical analysis
Statistical analyses were performed with SPSS® version 13
for Windows (SPSS Inc, Chicago, IL). Rasch analysis was
performed with the Winsteps programme (Linacre, 2007).
Results
Regarding glaucoma subjects, 43 patients had primary
open angle glaucoma (POAG), 10 had pseudoexfoliation
glaucoma (PXG), 16 had normal tension glaucoma
(NTG) and 15 subjects had ocular hypertension (OH).
The MD ranged from -1.9 dB to -7.1 dB in Humphrey 24-
2 threshold testing (mean: -3.2 dB). Regarding ARMD
subjects, 28 patients presented variable degrees of bilat-
eral geographical atrophy, while 2 patients presented exu-
dative changes in one eye. Regarding cataract subjects,
mean LOCS III score for nuclear opalescence was 3.1 and
LOCS III score for nuclear color was 3.3. Regarding the
dry-eye syndrome group, all subjects were treated with
artificial tears, 13 subjects reported that artificial tears
treatment was effective, while 17 subjects demonstrated
combined fluorescein score > 0.5. Demographics and clin-
ical data for the participants are presented in Table 1.
Mean subscale and overall NEI-VFQ scores for the differ-
ent groups of subjects are presented in Table 2. Mean NEI-
VFQ scores ranged from 81.6 ± 16.5 for the dry-eye patient
group to 70.9 ± 20.2 for the ARMD group. Control sub-
jects presented mean overall NEI-VFQ score of 93.7 ± 8.9.
Item analysis is presented in Table 3. The highest missing
values were identified in the questions regarding "Driv-
ing" (missing percentages of 13.4% and 68.2% in items
15 and 16 respectively). On the other hand, significantly
lower missing percentages were identified in the remain-
ing items with higher values (7.6%) both in item 22
("Have less control because of poor eyesight") and item
23 ("Rely on others because of poor eyesight"). Ceiling
and floor values of the sample suggested that the data was
not strongly skewed.
Evaluation of the reliability of the Greek version of the
NEI-VFQ 25 is presented in Table 4. Cronbach's alpha
ranged from 0.678 for the "Vision-specific social function-
ing" subscale to 0.926 for the "Vision specific role difficul-
ties". Nevertheless, the majority of the subscales presented
high internal consistency. Regarding test-retest reliability,
intraclass correlation coefficient was higher than 0.7 in all
subscales; it ranged from 0.717 for the "Color vision" to
0.910 for the "Vision-specific social functioning".
Evaluation of the validity of the Greek version of NEI-VFQ
25 is presented in the multitrait-multimethod matrix (see
Additional file 1) and Table 4. All items passed the conver-
gent and discriminant validity tests.
The impact of visual acuity and visual field deficits on
vision-specific quality of life is presented in Table 5.
Strong Pearson correlations were detected between BCVA
and the corresponding subscales that are associated with
central vision (i.e. general vision and near activities). Cor-
respondingly, strong Pearson correlations were detected
between VF scores and "peripheral vision" and "general
vision subscales".
Regarding Rasch analysis, the normalized item fit statistics
are presented in Table 6. The expected values are 0, with a
tolerance of ± 2 deviation units. Positive values indicate
that response residuals exceed expectations of the model,
whereas negative values indicate that response residuals
are less than the expectations of the model. Figure 1 illus-
trates the infit and outfit values for the list of items. Six
items fell outside the tolerance box. The most misfitting
Table 1: Demographics and clinical data
Glaucoma ARMD Cataract Dry Eye Control
Mean ± SD age (years) 60.9 ± 11.7 65 ± 4.4 63 ± 7.3 59.1 ± 8.7 56 ± 8.9
males/females 38/46 14/16 5/13 1/24 6/23
mean BCVA best (range) 0.63 (0.5 to 0.8) 0.4 (0.67 to 0.32) 0.5 (0.63 to 0.32) 0.8 (0.67 to 1.0) 1
mean BCVA worse (range) 0.4 (0.33 to 0.63) 0.33 (0.25 to 0.40) 0.29 (0.16 to 0.4) 0.67 (0.5 to 0.8) 0.8 (1 to 0.67)
VF MD (dB) (range) -3.2 (-7.1 to-1.9) - - - -
0 medical comorbitities 846 4 1 3
1 medical comorbitities 47 8 5 15 8
≥2 medical comorbitities 29 18 7 6 8BMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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items were the "overall eyesight" and the "overall health".
In accordance with other researchers, gross misfits to the
model were detected by the items that used agreement
instead of difficulty rating scales. However, when the
"agreement" items were removed from the model (table
7), the number of misfits decreased significantly (Figure
2).
Figure 3 illustrates the distribution of visual ability meas-
ures. Higher values indicate greater visual ability and less
disability. On the other hand, lower values indicate lower
Table 2: Index and subscale scores
Subject Group
NEI-VFQ 25 subscales Glaucoma ARMD Dry-eye Cataract Control
Mean SD Mean SD Mean SD Mean SD Mean SD
General health 55.3 20.3 57.6 17.1 45.9 17.2 57.8 19.7 80.3 12.2
General vision 69.6 15.5 56.6 10.9 75.1 15.2 60 17.4 90.7 12.9
Ocular pain 69.9 23.1 94.2 16 60.5 18.9 84 20.5 89.7 12.1
Near activities 78.7 18.7 58.6 23 86.2 16.3 65.6 26.9 96.1 9.7
Distance activities 82.2 19 74.4 17.7 90.2 13.9 74.7 18.5 96 7
Vision specific social functioning 89.2 19.4 89.1 12.8 94.1 9.7 84.3 22.9 99.4 3.1
Vision specific mental health 69.7 21.6 63.3 22.4 80.8 19.3 67.8 24.5 89.7 10.4
Vision specific role difficulties 74.3 21.7 59.8 24.4 86.5 18.7 68 29.3 94.8 12.1
Vision specific dependency 82.5 25.1 70.3 22.5 91.3 19.8 79.6 26.4 97.7 7
Driving 81.1 16.9 61.1 26.4 90 11.5 75 35.4 93.8 8
Color vision 88.3 19 86.7 23.4 89.3 22.1 86.1 17.6 100 0
Peripheral vision 82.4 21.4 79.2 25.5 89.6 15.4 79.4 28.3 95.7 11.7
Overall Score 76.9 20.2 70.9 20.2 81.6 16.5 73.5 24 93.7 8.9
Table 3: Item analysis
Item Missing responses Floor responses Ceiling responses
Number % Number % Number %
1. General Health: 5-level health rating 1 0.5 14 8.9 6 3.8
2. General Vision: 6-level general vision 1 0.5 1 0.6 6 3.8
3. Mental Health: Amount true: worry 2 1.3 21 13.4 11 7.0
4. Ocular Pain: Amount pain 2 1.3 1 0.6 55 35.0
5. Near Vision: Reading normal newsprint 4 2.5 21 13.4 38 24.2
6. Near Vision: See well up-close 1 0.5 1 0.6 46 29.3
7. Near Vision: Finding objects on crowded shelf 1 0.5 5 3.2 88 56.1
8. Distance Vision: Reading street signs 2 1.3 6 3.8 64 40.8
9. Distance Vision: Going down stairs at night 2 1.3 2 1.3 61 38.9
10. Peripheral Vision: Seeing objects off to side 2 1.3 1 0.6 82 52.2
11. Social Function: Seeing how people react 2 1.3 2 1.3 99 63.1
12. Color Vision: Difficulty matching clothes 1 0.5 1 0.6 101 64.3
13. Social Function: Visiting others 1 0.5 4 2.5 114 72.6
14. Distance Vision: Going out to movies/plays 6 3.8 56 35.7 56 35.7
15. Driving: Daylight familiar places 21 13.4 84 53.5 52 33.1
16. Driving: At night 50 68.2 1 0.6 12 7.6
17. Role Limitation: Accomplish less 8 5.1 6 3.8 53 33.8
18. Role Limitation: Limited in endurance 10 6.4 6 3.8 53 33.8
19. Ocular Pain: Amount time: pain 8 5.1 1 0.6 73 46.5
20. Dependency: Stay home most of time 6 3.8 14 8.9 80 51.0
21. Mental Health: Amount true: frustrated 9 5.7 11 7.0 76 48.4
22. Mental Health: Amount true: no control 12 7.6 6 3.8 84 53.5
23. Dependency: Rely too much on other's word 12 7.6 4 2.5 92 58.6
24. Dependency: Need much help from others 10 6.4 6 3.8 89 56.7
25. Mental Health: Amount true: embarrassment 9 5.7 8 5.1 100 63.7BMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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Table 4: Reliability and validity analysis
Subscale Number of items Intraclass 
correlation 
coefficients
Cronbach's alpha Range of item-scale 
correlations
Convergent validity Discriminant 
validity
General Health 1 0.841 NA NA NA NA
General Vision 1 0.889 NA NA NA NA
Ocular pain 2 0.803 0.851 0.893 – 0.903 100 100
Near activities 3 0.901 0.734 0.719 – 0.875 100 100
Distance 
activities
3 0.908 0.686 0.752 – 0.892 100 100
Vision specific 
social 
functioning
2 0.91 0.678 0.887 – 0.889 100 100
Vision specific 
mental health
4 0.823 0.786 0.596 – 0.837 100 100
Vision specific 
role difficulties
2 0.888 0.926 0.902 – 0.907 100 100
Vision specific 
dependency
3 0.826 0.848 0.835 – 0.899 100 100
Driving 3 0.871 0.757 0.575 – 0.953 100 100
Color vision 1 0.717 NA NA NA NA
Peripheral vision 1 0.84 NA NA NA NA
N.A.: Not applicable (needs two or more items).
Table 5: Pearson correlations of NEI VFQ 25 subscales with visual acuity and visual fields
BCVA worse BCVA better VF worse VF better
General Health Pearson Correlation -0.145 -0.078 -0.175 -0.145
Sig. (2-tailed) 0.231 0.521 0.153 0.238
General Vision Pearson Correlation -0.279(*) -0.251(*) -0.444(**) -0.407(**)
Sig. (2-tailed) 0.019 0.035 0 0.001
Ocular Pain Pearson Correlation -0.082 -0.065 -0.1 -0.216
Sig. (2-tailed) 0.499 0.589 0.415 0.075
Near Activities Pearson Correlation -0.331(**) -0.337(**) -0.361(**) -0.411(**)
Sig. (2-tailed) 0.005 0.004 0.002 0
Distant Activities Pearson Correlation -0.440(**) -0.159 -0.260(*) -0.346(**)
Sig. (2-tailed) 0 0.186 0.031 0.004
Social Functioning Pearson Correlation -0.369(**) -0.159 -0.227 -0.295(*)
Sig. (2-tailed) 0.002 0.184 0.061 0.014
Mental Health Pearson Correlation -0.236(*) -0.172 -0.021 -0.083
Sig. (2-tailed) 0.047 0.15 0.862 0.498
Role Difficulties Pearson Correlation -0.218 -0.199 -0.204 -0.242
Sig. (2-tailed) 0.074 0.103 0.1 0.05
Dependency Pearson Correlation -0.475(**) -0.242 -0.174 -0.292(*)
Sig. (2-tailed) 0 0.065 0.196 0.028
N5 9 5 9 5 7 5 7
Driving Pearson Correlation -0.239 -0.134 -0.371(*) -0.041
Sig. (2-tailed) 0.187 0.466 0.04 0.826
N3 2 3 2 3 1 3 1
Color vision Pearson Correlation -0.405(**) -0.345(**) -0.231 -0.288(*)
Sig. (2-tailed) 0.001 0.004 0.062 0.019
Peripheral vision Pearson Correlation -0.22 -0.087 -0.334(**) -0.336(**)
Sig. (2-tailed) 0.07 0.478 0.006 0.005
**: Correlation is significant at the 0.01 level (2-tailed).
*: Correlation is significant at the 0.05 level (2-tailed).BMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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visual ability and suggest that the subject is more disabled.
The distributions of the infit and outfit statistics for the
estimates of visual ability are presented in Figure 4.
Twenty six percent of the patients had fit statistics that fell
outside the ± 2 tolerance box.
Discussion
The primary objective of our study was the evaluation of
the reliability and construct validity of the NEI-VFQ 25 in
native Greek populations with a series of common oph-
thalmic diseases. Proper adaptation of the instrument to
the Greek norms mandated slight modification of some
items and a thorough revision of the translation process
that had already been performed by previous investiga-
tors. Minor modifications of some items were considered
necessary during the translation and validation of the
NEI-VFQ 25 in other populations, too [12,13,15].
Contrary to the original validation studies in North Amer-
ican populations, relatively high missing rates were
encountered in some subscales. However, these missing
rates were comparably lower than the ones encountered
during the translation and validation of the instrument in
other populations [13]. In fact, except for the "Driving"
subscale, no significant missing rates were found. Thus,
contrary to what Suzukamo and collaborators did, in our
study no substitution was performed between the regular
Infit and outfit values for the list of items – "agreement" items  removed from model Figure 2
Infit and outfit values for the list of items – "agreement" items 
removed from model.
Table 6: Estimates of item measures and fit statistics from Rasch analysis
Item Item Number ρ Standard Error Infit zstd Outfit zstd
Matching clothes 12 -1.07 0.14 0.00 -0.20
Finding something 7 -0.92 0.13 0.10 -0.30
See reaction 11 -0.92 0.13 2.20 2.00
Visit people 13 -0.82 0.12 -0.70 -1.30
Noticing objects 10 -0.7 0.11 -0.70 -0.90
Eye pain 4 -0.42 0.10 -2.30 -3.00
Going down steps 9 -0.41 0.10 -1.80 -2.10
Reading signs 8 -0.4 0.10 -0.20 -0.50
See up close 6 -0.29 0.09 0.30 -0.20
Overall eyesight 2 -0.1 0.09 -6.90 -6.60
Reading print 5 -0.03 0.09 2.70 2.60
Overall health 1 0.15 0.08 5.80 5.40
Worry about eyesight 3 0.2 0.09 -1.20 -0.90
See movies 14 0.24 0.09 6.90 6.80
Limited 18 0.32 0.09 1.30 1.60
Accomplish less 17 0.32 0.09 -0.40 0.30
Stay home 20 0.44 0.09 1.10 1.40
Feel frustrated 21 0.48 0.09 1.20 0.90
Less control 22 0.69 0.10 0.00 0.40
Need help 24 0.71 0.10 -2.90 -1.60
Eye discomfort 19 0.72 0.10 -0.70 -0.10
Rely too much 23 0.88 0.11 0.60 0.60
Embarrass myself 25 0.94 0.11 -0.60 0.00
Infit and outfit values for the list of items Figure 1
Infit and outfit values for the list of items.BMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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items with high missing rates and the corresponding
optional ones with low missing rates within selected sub-
scales [13]. On the other hand, high ceiling percentages
were encountered in some items (i.e. "Social function: vis-
iting others" and "Driving: driving at night"). However,
no significant skewing of data was detected.
The subscales of the Greek version of NEI-VFQ 25 pre-
sented variable but adequate internal consistencies indi-
cating high reliability of the instrument in the population
studied. The lowest values of Cronbach's alpha were
detected in "Social Functioning" (0.678) and "Distance
Activities" (0.686) subscales, while the rest of the sub-
scales presented significantly higher values. On the other
hand, the time-window of three weeks between test and
retest visits, ensured that no significant changes in the
vision-related and/or systemic functional status of the
subjects would take place. In fact, solid test-retest reliabil-
ity was indicated by the high values of the intraclass corre-
lation coefficients.
Regarding the construct validation of the questionnaire,
none of the items failed either the convergent or the dis-
criminant tests.
Strong correlations were detected between visual acuity of
the subjects and the "general vision", "distant activities"
and "near activities" subscales suggesting that the corre-
sponding subscales were actually associated with central
vision. Similar correlations between visual acuity and
NEI-VFQ subscales have been detected by previous inves-
tigators during the validation of the instrument in other
languages as well [14,15]. Moreover, in accordance to the
concepts investigated by the corresponding items, the vis-
ual fields deficits of glaucoma subjects were associated
with "peripheral vision" and "general vision" subscales. In
fact, the results of our study regarding the impact of visual
fields deficits on VS-QoL are similar to the ones by
Ringsdorf and coworkers for the white, non-Hispanic
population of their study [34].
On the other hand, item response analysis revealed poten-
tial weaknesses of the questionnaire that should be taken
into consideration prior to the interpretation of results.
These potential weaknesses are associated with the
assumptions of the Rasch model. Among these assump-
tions are: a) only one variable is measured by the instru-
Distribution of the infit and outfit statistics for the estimates  of visual ability Figure 4
Distribution of the infit and outfit statistics for the estimates 
of visual ability.
Table 7: Estimates of item measures and fit statistics from Rasch analysis (difficulty items only)
Item Item number ρ Standard Error Infit zstd Outfit zstd
Matching clothes 12 -0.77 0.16 -0.70 -2.50
Finding something 7 -0.58 0.15 1.90 1.30
See reaction 11 -0.58 0.15 -0.10 0.50
Visit people 13 -0.43 0.14 -1.30 0.40
Noticing objects 10 -0.27 0.13 1.90 1.00
Going down steps 9 0.16 0.12 2.80 1.70
Reading signs 8 0.18 0.12 -0.10 -0.20
See up-close 6 0.34 0.11 0.90 -0.20
Reading print 5 0.74 0.11 -1.10 -0.80
See movies 14 1.2 0.11 -3.30 -1.70
Distribution of visual ability measures Figure 3
Distribution of visual ability measures.BMC Ophthalmology 2008, 8:4 http://www.biomedcentral.com/1471-2415/8/4
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ment, b) subjects' responses to the items depend only on
visual ability, c) subjects' responses are probabilistic and
conditional on the subjects' visual ability required to per-
form that activity with ease, d) the odds of performing an
activity with ease increase monotonically with the differ-
ence between the subject's ability and the ability required
to perform the activity with ease. The results of the study
indicate that the items requiring agreement ratings pre-
sented low precision in the estimation of the latent varia-
ble, contrary to the items requiring difficulty ratings,
which presented higher precision. However, other investi-
gators have presented similar results on their evaluation
of the performance of certain NEI-VFQ items [35]. This
suggests potential inherent validity issues related to the
original instrument, rather than its translation and adap-
tation to the Greek language. Nonetheless, the important
limitations of the scale detected with Rasch analysis may
make it unsuitable for use.
Besides the aforementioned potential weakness of the
instrument, certain limitations of our study may have to
be considered. The translation process presented minor
deviations from international recommendations. How-
ever, the research team is confident that these minor devi-
ations had no actual impact on the translated outcome.
On the other hand, the results are valid for the corre-
sponding conditions of the patient groups and for the self-
administered version of the instrument. Thus, prior to the
usage of the instrument as a reliable index of VS-QoL in
Greek patients with other diseases (i.e. diabetic retinopa-
thy), further validation may be necessary in an appropri-
ate sample of patients.
A series of vision-specific QoL studies conducted in
homogenous populations have assessed the impact of sys-
temic or ocular diseases on VS-QoL [1,2,36]. The out-
comes of these studies could potentially modify the
overall thinking on chronic disease management, since
the patients' subjective perceptions regarding their visual
impairment are not always in accordance with objective
clinical parameters like the visual acuity or the visual
fields. Literature suggests that in selective cases, non-clin-
ical parameters such as educational background, financial
state, or awareness regarding the disease have greater
impact on the quality of life than objective clinical indices
[37].
The majority of VS-QoL instruments attempt to quantify
QoL by evaluating potential difficulties during a wide
range of daily activities. It becomes obvious that the per-
formance of QoL instruments (i.e. reliable assessment of
subjective difficulty) depends heavily on the proper adap-
tation of the items to the cultural characteristics of the
population studied, especially if the instrument was orig-
inally developed for a population with a different cultural
background.
Conclusion
Our results indicate that according to traditional valida-
tion methods, the Greek version of the NEI-VFQ 25 is a
valid and reliable instrument for the assessment of VS-
QoL in native populations. These findings are in agree-
ment with the majority of previous research that trans-
lated and validated the instrument in series of ophthalmic
patients by means of traditional validation methods, thus
providing the theoretical framework for numerous VS-
QoL studies. On the other hand, Rasch analysis revealed
important misfits to the model, mainly of the "agree-
ment" items, suggesting that the results of the correspond-
ing subscales have to be interpreted with extreme caution.
The significant limitations detected with Rasch analysis
may render the instrument unsuitable for use. Further
research is warranted for the re-evaluation of the perform-
ance of NEI-VFQ 25 as a VS-QoL instrument.
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